Two-Step Non-Affinity Chromatography for Protein Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protein purification methods, particularly in the biopharmaceutical industry, face challenges in achieving therapeutic-grade purity efficiently and cost-effectively due to the reliance on affinity chromatography and multi-step processes, which are expensive and prone to resin instability, and often require additional steps like tangential flow filtration, increasing costs and complexity.
Innovation Solution
A two-step non-affinity chromatography process using cation exchange chromatography and hydrophobic charge induction chromatography without an in-process tangential flow filtration step, where pH manipulations are employed between the steps to achieve high purity of recombinant proteins such as monoclonal antibodies, reducing costs and simplifying the purification scheme.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If affinity chromatography (Protein A) is used to purify antibodies, then purification efficiency and purity are improved, but cost and resin instability worsen
Solution Approach 1:
The invention segments the purification process into two distinct non-affinity chromatography steps: cation exchange chromatography (CEX) followed by hydrophobic interaction chromatography (HIC). This segmentation replaces the single affinity chromatography step, achieving therapeutic-grade purity through sequential separation mechanisms while avoiding the high costs and instability issues of Protein A resin.
Solution Approach 2:
The invention utilizes parameter changes in pH and salt concentration to optimize the two-step non-affinity chromatography process. By adjusting pH conditions during CEX and salt concentration during HIC, the process achieves high purity separation without relying on affinity resin, thereby reducing cost and improving manufacturability.
2Manufacturing precision
If multiple purification steps are combined to achieve adequate purity, then purity requirement is met, but cost and process complexity increase
Solution Approach 1:
The invention merges the separation functions of cation exchange and hydrophobic interaction chromatography into a streamlined two-step process. By combining these complementary mechanisms, the process achieves adequate purity for therapeutic use while maintaining relatively simple operation and avoiding the need for additional tangential flow filtration steps.
3Reliability
If affinity chromatography resin is used, then binding affinity for antibodies is improved, but resin stability and cleaning difficulty worsen
Solution Approach 1:
The invention employs disposable or easily replaceable non-affinity chromatography resins that do not suffer from the stability and ligand leakage problems of Protein A. These resins can be cleaned more easily and replaced at lower cost, eliminating the resin instability issues while maintaining effective purification through sequential CEX and HIC steps.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces host cell protein and nucleic acid contaminants to negligible levels, achieving therapeutic-grade purity with fewer steps and lower costs, enhancing the efficiency and productivity of protein purification while maintaining molecular integrity.
Implementation Method 1
cation exchange chromatography
Implementation Method 2
hydrophobic charge induction chromatography
Data Source
AI summary
The present invention provides methods for purifying proteins. In particular, the methods employ a two-step non-affinity chromatography process without the use of an in-process tangential flow filtration step.